Bone cancer patients in England are to be denied a life-prolonging drug which is available across the border, it has been reported.
Velcade was approved for use in Scotland in 1994 but according to the Daily Mail, the National Health Service's drug rationing body will announce next week that it is refusing to fund its use in England.
Continue reading English 'denied bone cancer drug'.